- An article on The Hill offers an outlook on the Medicare drug price negotiation legal battle. As of last week, three pharmaceutical companies and two trade groups are now suing the federal government over the Medicare Drug Price Negotiation Program established through the Inflation Reduction Act (IRA). The Hill discusses the timeline of negotiations and the expected legal arguments from the organizations. (Article here)
July 31, 2023
Life Sciences | Tea Leaves